aluates Reports

$ 0.0

Automative

Global Factor IX Deficiency Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-37A6004

Global Factor IX Deficiency Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Factor IX Deficiency Treatment Market Research Report 2025

Code: QYRE-Auto-37A6004

Report

September 2025

Pages:67

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Takeda

Novo Nordisk

Biogen

CSL Behring

Factor IX Deficiency Treatment Market

The global market for Factor IX Deficiency Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.

In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market during the forecast period. Factors such a low cost and high efficiency are the key contributors to the dominance of this segment in the global market.

This report aims to provide a comprehensive presentation of the global market for Factor IX Deficiency Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Deficiency Treatment.

The Factor IX Deficiency Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Factor IX Deficiency Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Factor IX Deficiency Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Factor IX Deficiency Treatment Market Report

Report Metric	Details
Report Name	Factor IX Deficiency Treatment Market
Segment by Type	Hemophilia B Hemophilia B Inhibitors
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Takeda, Novo Nordisk, Biogen, CSL Behring
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Factor IX Deficiency Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Factor IX Deficiency Treatment Market report?

Ans: The main players in the Factor IX Deficiency Treatment Market are Pfizer, Takeda, Novo Nordisk, Biogen, CSL Behring

What are the Application segmentation covered in the Factor IX Deficiency Treatment Market report?

Ans: The Applications covered in the Factor IX Deficiency Treatment Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Factor IX Deficiency Treatment Market report?

Ans: The Types covered in the Factor IX Deficiency Treatment Market report are Hemophilia B, Hemophilia B Inhibitors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Factor IX Deficiency Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Hemophilia B

1.2.3 Hemophilia B Inhibitors

1.3 Market by Application

1.3.1 Global Factor IX Deficiency Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Factor IX Deficiency Treatment Market Perspective (2020-2031)

2.2 Global Factor IX Deficiency Treatment Growth Trends by Region

2.2.1 Global Factor IX Deficiency Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Factor IX Deficiency Treatment Historic Market Size by Region (2020-2025)

2.2.3 Factor IX Deficiency Treatment Forecasted Market Size by Region (2026-2031)

2.3 Factor IX Deficiency Treatment Market Dynamics

2.3.1 Factor IX Deficiency Treatment Industry Trends

2.3.2 Factor IX Deficiency Treatment Market Drivers

2.3.3 Factor IX Deficiency Treatment Market Challenges

2.3.4 Factor IX Deficiency Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Factor IX Deficiency Treatment Players by Revenue

3.1.1 Global Top Factor IX Deficiency Treatment Players by Revenue (2020-2025)

3.1.2 Global Factor IX Deficiency Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Factor IX Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Factor IX Deficiency Treatment Revenue

3.4 Global Factor IX Deficiency Treatment Market Concentration Ratio

3.4.1 Global Factor IX Deficiency Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Factor IX Deficiency Treatment Revenue in 2024

3.5 Global Key Players of Factor IX Deficiency Treatment Head office and Area Served

3.6 Global Key Players of Factor IX Deficiency Treatment, Product and Application

3.7 Global Key Players of Factor IX Deficiency Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Factor IX Deficiency Treatment Breakdown Data by Type

4.1 Global Factor IX Deficiency Treatment Historic Market Size by Type (2020-2025)

4.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2026-2031)

5 Factor IX Deficiency Treatment Breakdown Data by Application

5.1 Global Factor IX Deficiency Treatment Historic Market Size by Application (2020-2025)

5.2 Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Factor IX Deficiency Treatment Market Size (2020-2031)

6.2 North America Factor IX Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Factor IX Deficiency Treatment Market Size by Country (2020-2025)

6.4 North America Factor IX Deficiency Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Factor IX Deficiency Treatment Market Size (2020-2031)

7.2 Europe Factor IX Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Factor IX Deficiency Treatment Market Size by Country (2020-2025)

7.4 Europe Factor IX Deficiency Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Factor IX Deficiency Treatment Market Size (2020-2031)

8.2 Asia-Pacific Factor IX Deficiency Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Factor IX Deficiency Treatment Market Size (2020-2031)

9.2 Latin America Factor IX Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Factor IX Deficiency Treatment Market Size by Country (2020-2025)

9.4 Latin America Factor IX Deficiency Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Factor IX Deficiency Treatment Market Size (2020-2031)

10.2 Middle East & Africa Factor IX Deficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Factor IX Deficiency Treatment Introduction

11.1.4 Pfizer Revenue in Factor IX Deficiency Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Takeda

11.2.1 Takeda Company Details

11.2.2 Takeda Business Overview

11.2.3 Takeda Factor IX Deficiency Treatment Introduction

11.2.4 Takeda Revenue in Factor IX Deficiency Treatment Business (2020-2025)

11.2.5 Takeda Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Factor IX Deficiency Treatment Introduction

11.3.4 Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Biogen

11.4.1 Biogen Company Details

11.4.2 Biogen Business Overview

11.4.3 Biogen Factor IX Deficiency Treatment Introduction

11.4.4 Biogen Revenue in Factor IX Deficiency Treatment Business (2020-2025)

11.4.5 Biogen Recent Development

11.5 CSL Behring

11.5.1 CSL Behring Company Details

11.5.2 CSL Behring Business Overview

11.5.3 CSL Behring Factor IX Deficiency Treatment Introduction

11.5.4 CSL Behring Revenue in Factor IX Deficiency Treatment Business (2020-2025)

11.5.5 CSL Behring Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Takeda

Novo Nordisk

Biogen

CSL Behring

List of Tables

Table 1. Global Factor IX Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Hemophilia B

Table 3. Key Players of Hemophilia B Inhibitors

Table 4. Global Factor IX Deficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Factor IX Deficiency Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Factor IX Deficiency Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Factor IX Deficiency Treatment Market Share by Region (2020-2025)

Table 8. Global Factor IX Deficiency Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Factor IX Deficiency Treatment Market Share by Region (2026-2031)

Table 10. Factor IX Deficiency Treatment Market Trends

Table 11. Factor IX Deficiency Treatment Market Drivers

Table 12. Factor IX Deficiency Treatment Market Challenges

Table 13. Factor IX Deficiency Treatment Market Restraints

Table 14. Global Factor IX Deficiency Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Factor IX Deficiency Treatment Market Share by Players (2020-2025)

Table 16. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor IX Deficiency Treatment as of 2024)

Table 17. Ranking of Global Top Factor IX Deficiency Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Factor IX Deficiency Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Factor IX Deficiency Treatment, Headquarters and Area Served

Table 20. Global Key Players of Factor IX Deficiency Treatment, Product and Application

Table 21. Global Key Players of Factor IX Deficiency Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Factor IX Deficiency Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Factor IX Deficiency Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Factor IX Deficiency Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Factor IX Deficiency Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Factor IX Deficiency Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Factor IX Deficiency Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Factor IX Deficiency Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Factor IX Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Factor IX Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Factor IX Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Factor IX Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Factor IX Deficiency Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Factor IX Deficiency Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Factor IX Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Factor IX Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Factor IX Deficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Factor IX Deficiency Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Factor IX Deficiency Treatment Product

Table 49. Pfizer Revenue in Factor IX Deficiency Treatment Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Takeda Company Details

Table 52. Takeda Business Overview

Table 53. Takeda Factor IX Deficiency Treatment Product

Table 54. Takeda Revenue in Factor IX Deficiency Treatment Business (2020-2025) & (US$ Million)

Table 55. Takeda Recent Development

Table 56. Novo Nordisk Company Details

Table 57. Novo Nordisk Business Overview

Table 58. Novo Nordisk Factor IX Deficiency Treatment Product

Table 59. Novo Nordisk Revenue in Factor IX Deficiency Treatment Business (2020-2025) & (US$ Million)

Table 60. Novo Nordisk Recent Development

Table 61. Biogen Company Details

Table 62. Biogen Business Overview

Table 63. Biogen Factor IX Deficiency Treatment Product

Table 64. Biogen Revenue in Factor IX Deficiency Treatment Business (2020-2025) & (US$ Million)

Table 65. Biogen Recent Development

Table 66. CSL Behring Company Details

Table 67. CSL Behring Business Overview

Table 68. CSL Behring Factor IX Deficiency Treatment Product

Table 69. CSL Behring Revenue in Factor IX Deficiency Treatment Business (2020-2025) & (US$ Million)

Table 70. CSL Behring Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

Table 74. Authors List of This Report

List of Figures

Figure 1. Factor IX Deficiency Treatment Picture

Figure 2. Global Factor IX Deficiency Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Factor IX Deficiency Treatment Market Share by Type: 2024 VS 2031

Figure 4. Hemophilia B Features

Figure 5. Hemophilia B Inhibitors Features

Figure 6. Global Factor IX Deficiency Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Factor IX Deficiency Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Other Case Studies

Figure 11. Factor IX Deficiency Treatment Report Years Considered

Figure 12. Global Factor IX Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Factor IX Deficiency Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Factor IX Deficiency Treatment Market Share by Region: 2024 VS 2031

Figure 15. Global Factor IX Deficiency Treatment Market Share by Players in 2024

Figure 16. Global Top Factor IX Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor IX Deficiency Treatment as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Factor IX Deficiency Treatment Revenue in 2024

Figure 18. North America Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Factor IX Deficiency Treatment Market Share by Country (2020-2031)

Figure 20. United States Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Factor IX Deficiency Treatment Market Share by Country (2020-2031)

Figure 24. Germany Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Factor IX Deficiency Treatment Market Share by Region (2020-2031)

Figure 32. China Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Factor IX Deficiency Treatment Market Share by Country (2020-2031)

Figure 40. Mexico Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Factor IX Deficiency Treatment Market Share by Country (2020-2031)

Figure 44. Turkey Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Factor IX Deficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Factor IX Deficiency Treatment Business (2020-2025)

Figure 48. Takeda Revenue Growth Rate in Factor IX Deficiency Treatment Business (2020-2025)

Figure 49. Novo Nordisk Revenue Growth Rate in Factor IX Deficiency Treatment Business (2020-2025)

Figure 50. Biogen Revenue Growth Rate in Factor IX Deficiency Treatment Business (2020-2025)

Figure 51. CSL Behring Revenue Growth Rate in Factor IX Deficiency Treatment Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Coagulation Factor VIII Market Research Report 2020

Global Human Prothrombin Complex Market Research Report 2025

Global Hemophilia Treatment Medications Market Research Report 2024

Factor IX Complex Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medication for Hemophilia Market Research Report 2024

Global Human Coagulation Factor IX Market Research Report 2024

Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Coagulation Factor IX Market Research Report 2025

Global Human Coagulation Factor VII Market Insights Forecast to 2030

Rare Hemophilia Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Factor Xa Market Research Report 2025

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Factor VIII Deficiency Treatment Market

Global Prothrombin Complex Market Research Report 2024

Human Prothrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prothrombin Complex Concentrate PCC Market Research Report 2024

Global Hemophilia Medication Market Research Report 2024

Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions